Biopharmaceutical benchmarks: Less than 20 years after the first biopharmaceutical, insulin, was approved, a new generation of products is superseding replacement proteins and enzyme therapies in biotechnology's pipeline

G. Walsh

doi:10.1038/78720

Biopharmaceutical benchmarks: Less than 20 years after the first biopharmaceutical, insulin, was approved, a new generation of products is superseding replacement proteins and enzyme therapies in biotechnology's pipeline

G. Walsh

Department of Chemical Sciences

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	831-833
Number of pages	3
Journal	Nature Biotechnology
Volume	18
Issue number	8
DOIs	https://doi.org/10.1038/78720
Publication status	Published - 2000

Access to Document

10.1038/78720

Cite this

@article{010797c1ea44444c971a0951eb29fefc,

title = "Biopharmaceutical benchmarks: Less than 20 years after the first biopharmaceutical, insulin, was approved, a new generation of products is superseding replacement proteins and enzyme therapies in biotechnology's pipeline",

author = "G. Walsh",

year = "2000",

doi = "10.1038/78720",

language = "English",

volume = "18",

pages = "831--833",

journal = "Nature Biotechnology",

issn = "1087-0156",

number = "8",

}

TY - JOUR

T1 - Biopharmaceutical benchmarks

T2 - Less than 20 years after the first biopharmaceutical, insulin, was approved, a new generation of products is superseding replacement proteins and enzyme therapies in biotechnology's pipeline

AU - Walsh, G.

PY - 2000

Y1 - 2000

UR - https://www.scopus.com/pages/publications/0034241572

U2 - 10.1038/78720

DO - 10.1038/78720

M3 - Review article

C2 - 10932150

AN - SCOPUS:0034241572

SN - 1087-0156

VL - 18

SP - 831

EP - 833

JO - Nature Biotechnology

JF - Nature Biotechnology

IS - 8

ER -

Biopharmaceutical benchmarks: Less than 20 years after the first biopharmaceutical, insulin, was approved, a new generation of products is superseding replacement proteins and enzyme therapies in biotechnology's pipeline

Access to Document

Other files and links

Cite this